EP1732939A4 - Assays auf nucleinsäurebasis zur identifizierung von fc-rezeptor-polymorphismen - Google Patents

Assays auf nucleinsäurebasis zur identifizierung von fc-rezeptor-polymorphismen

Info

Publication number
EP1732939A4
EP1732939A4 EP04815738A EP04815738A EP1732939A4 EP 1732939 A4 EP1732939 A4 EP 1732939A4 EP 04815738 A EP04815738 A EP 04815738A EP 04815738 A EP04815738 A EP 04815738A EP 1732939 A4 EP1732939 A4 EP 1732939A4
Authority
EP
European Patent Office
Prior art keywords
identification
nucleic acid
based assays
acid based
receptor polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04815738A
Other languages
English (en)
French (fr)
Other versions
EP1732939A2 (de
Inventor
Pablo G Garcia
Susan E Wilson
Gene Guozhong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Publication of EP1732939A2 publication Critical patent/EP1732939A2/de
Publication of EP1732939A4 publication Critical patent/EP1732939A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP04815738A 2004-04-07 2004-12-22 Assays auf nucleinsäurebasis zur identifizierung von fc-rezeptor-polymorphismen Withdrawn EP1732939A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56064904P 2004-04-07 2004-04-07
PCT/US2004/043726 WO2005102379A2 (en) 2004-04-07 2004-12-22 Nucleic acid based assays for identification of fc receptor polymorphisms

Publications (2)

Publication Number Publication Date
EP1732939A2 EP1732939A2 (de) 2006-12-20
EP1732939A4 true EP1732939A4 (de) 2008-09-17

Family

ID=35197498

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04815738A Withdrawn EP1732939A4 (de) 2004-04-07 2004-12-22 Assays auf nucleinsäurebasis zur identifizierung von fc-rezeptor-polymorphismen

Country Status (10)

Country Link
EP (1) EP1732939A4 (de)
JP (1) JP2007532110A (de)
KR (1) KR20070004082A (de)
CN (1) CN1976942A (de)
AU (1) AU2004318681A1 (de)
BR (1) BRPI0418722A (de)
CA (1) CA2562016A1 (de)
IL (1) IL178333A0 (de)
RU (1) RU2006138865A (de)
WO (1) WO2005102379A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181016A1 (en) * 2005-11-30 2009-07-16 University Of Southern California FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
EP2109686A2 (de) 2007-01-18 2009-10-21 University Of Southern California Genetische marker zur vorhersage des ansprechens auf eine kombinationstherapie
WO2009026502A1 (en) * 2007-08-22 2009-02-26 Wyeth Nested pcr-based method for specific genotyping of the fc-gamma receptor iiia gene
JP2016534749A (ja) * 2013-10-15 2016-11-10 コネクシオ ゲノミクス ピーティーワイ リミテッド 主要組織適合遺伝子複合体一塩基多型
WO2021146521A1 (en) * 2020-01-16 2021-07-22 Acepodia Biotechnologies Ltd. A novel cd16+ natural killer cell and a method of culturing cd16+ natural killer cell
CN114277149B (zh) * 2021-12-30 2023-09-22 苏州方科生物科技有限公司 一种检测cd16a基因多态性的试剂盒及其应用和使用方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035904A2 (en) * 2001-10-19 2003-05-01 Centre Hospitalier Regional Et Universitaire De Tours Methods and compositions to evaluate antibody treatment response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035904A2 (en) * 2001-10-19 2003-05-01 Centre Hospitalier Regional Et Universitaire De Tours Methods and compositions to evaluate antibody treatment response

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LEPPERS-VAN DE STRAAT F G J ET AL: "A novel PCR-based method for direct Fcgamma receptor IIIa (CD16) allotyping", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 242, no. 1-2, 28 August 2000 (2000-08-28), pages 127 - 132, XP004210716, ISSN: 0022-1759 *
RAVETCH J V ET AL: "ALTERNATIVE MEMBRANE FORMS OF FCGAMMARIII(CD16) ON HUMAN NATURAL KILLER CELLS AND NEUTROPHILS. ÖCELL TYPE-SPECIFIC EXPRESSION OF TWO GENES THAT DIFFER IN SINGLE NUCLEOTIDE SUBSTITUTIONS", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 170, no. 2, 1 August 1989 (1989-08-01), pages 481 - 497, XP000604942, ISSN: 0022-1007 *

Also Published As

Publication number Publication date
JP2007532110A (ja) 2007-11-15
EP1732939A2 (de) 2006-12-20
CN1976942A (zh) 2007-06-06
RU2006138865A (ru) 2008-05-20
KR20070004082A (ko) 2007-01-05
IL178333A0 (en) 2007-02-11
WO2005102379A2 (en) 2005-11-03
CA2562016A1 (en) 2005-11-03
BRPI0418722A (pt) 2007-09-11
AU2004318681A1 (en) 2005-11-03
WO2005102379A3 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
HK1126824A1 (en) Integrated nucleic acid assays
EP1806393A4 (de) Mikroreaktor für genetischen test
EP1841890A4 (de) Primer für nukleinsäurenachweis
SI1899488T1 (sl) Potrditveni test na čipu zajetih kromosomov (4c)
IL175965A0 (en) Montelukast free acid polymorphs
EP1737985A4 (de) System für den nachweis von nukleinsäuren
IL177812A0 (en) Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
EP2089517A4 (de) Polymeraseenzyme und reagenzien für erweiterte nukeinsäuresequenzierung
AU2003900368A0 (en) Assay for nucleic acid molecules
IL182107A0 (en) Genomic assay
EP2123752A4 (de) Neuartige nukleinsäure
EP1943254A4 (de) Reagentien zum hochspezifischen nachweis von peroxynitrit
EP2077326A4 (de) Neuartige nukleinsäure
HK1124888A1 (zh) 用於核酸測試的對照
IL178333A0 (en) Nucleic acid based assays for identification of fc receptor polymorphisms
HK1134324A1 (en) Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
EP1910568A4 (de) Multiplex-polymerasekettenreaktion zur gentechnischen sequenzanalyse
AU2003240377A8 (en) Lab-on-chip system for analying nucleic acid
EP1772730A4 (de) Reagenz zur bleibestimmung
ZA200700139B (en) Silicon refining installation
GB0406863D0 (en) Nucleic acid sequencing
EP1750722A4 (de) Neue lysophosphatidsäure-rezeptorselektive antagonisten
EP1788082A4 (de) Nukleinsäurekonstrukt
EP2085473A4 (de) Hilfsreagens für gentransfer
EP1949152A4 (de) Planare wellenleiter-erkennungschips und kammer zur ausführung von multiplex-pcr-tests

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061010

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080818

17Q First examination report despatched

Effective date: 20081203

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090616